Stock HYL HYLORIS PHARMACEUTICALS SA
Add to a list
To use this feature you must be a member
Log inSign up
PDF Report : Hyloris Pharmaceuticals SA

Transcripts Hyloris Pharmaceuticals SA

Equities

HYL

BE0974363955

Real-time Euronext Bruxelles
Other stock markets
 10:27:44 2023-12-05 am EST 		Intraday chart for Hyloris Pharmaceuticals SA 5-day change 1st Jan Change
12.35 EUR -1.20% -0.80% +6.47%
Dec. 04 Hyloris Pharmaceuticals Partner Gets US FDA Nod for Warts Gel MT
Oct. 26 Kye Pharmaceuticals Partners with Hyloris Pharmaceuticals for the Development and Commercialization of Atomoxetine Oral Solution in Canada CI

Transcripts

Search
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Hyloris Pharmaceuticals SA, H1 2023 Earnings Call, Sep 07, 2023
CI
Transcript : Hyloris Pharmaceuticals SA, 2022 Earnings Call, Mar 16, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Announcement Date

Since

Until

  1. Stock
  2. Equities
  3. Stock Hyloris Pharmaceuticals SA - Euronext Bruxelles
  4. News Hyloris Pharmaceuticals SA
  5. Transcripts
As early as today, start finding the best investment opportunities!
Optimize my profits
fermer